[1]
|
Meex, R.C.R. and Watt, M.J. (2017) Hepatokines: Linking Nonalcoholic Fatty Liver Disease and Insulin Resistance. Nature Reviews Endocrinology, 13, 509-520. https://doi.org/10.1038/nrendo.2017.56
|
[2]
|
Sarin, S.K., Kumar, M., Eslam, M., et al. (2020) Liver Diseases in the Asia-Pacific Region: A Lancet Gastroenterology & Hepatology Commis-sion. The Lancet Gastroenterology & Hepatology, 5, 167-228.
https://doi.org/10.1016/S2468-1253(19)30342-5
|
[3]
|
夏明锋, 卞华, 高鑫. 从非酒精性脂肪肝到代谢相关性脂肪肝命名变化的思考[J/OL]. 中华糖尿病杂志, 2020, 12(7): 445-450. https://doi.org/10.3760/cma.j.cn115791-20200324-00175
|
[4]
|
Eslam, M., Sarin, S.K., Wong, V.W.S., et al. (2020) The Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines for the Diagnosis and Management of Metabolic Associated Fatty Liver Disease. Hepatology International, 14, 889-919. https://doi.org/10.1007/s12072-020-10094-2
|
[5]
|
Eslam, M., Sanyal, A.J., George, J., et al. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 158, 1999-2014.e1. https://doi.org/10.1053/j.gastro.2019.11.312
|
[6]
|
张成岗, 王雅娜. 研究脂肪肝患者的肝功能与血脂、血糖检测结果异常的关系[J/OL]. 世界最新医学信息文摘, 2019, 19(40): 158-159. https://doi.org/10.19613/j.cnki.1671-3141.2019.40.102
|
[7]
|
吴广忠, 苏建友. 肝功能血脂血糖联合检测在脂肪肝患者中的应用价值[J/OL]. 实用医技杂志, 2021, 28(7): 899-901. https://doi.org/10.19522/j.cnki.1671-5098.2021.07.023
|
[8]
|
Lebreton, J.P., Joisel, F., Raoult, J.P., et al. (1979) Serum Concentration of Human Alpha 2 HS Glycoprotein during the Inflammatory Process: Evidence That Alpha 2 HS Glycoprotein Is a Negative Acute-Phase Reactant. Journal of Clinical Investigation, 64, 1118-1129. https://doi.org/10.1172/JCI109551
|
[9]
|
Sardana, O., Goyal, R. and Bedi, O. (2021) Molecular and Pathobiological Involvement of Fetuin-A in the Pathogenesis of NAFLD. Inflammopharmacology, 29, 1061-1074. https://doi.org/10.1007/s10787-021-00837-4
|
[10]
|
张瑞, 刘东方. 胎球蛋白B对糖脂代谢影响的研究进展[J/OL]. 重庆医科大学学报, 2021, 46(9): 1031-1034.
https://doi.org/10.13406/j.cnki.cyxb.002663
|
[11]
|
Cui, Z., Xuan, R. and Yang, Y. (2017) Serum Fetuin A Level Is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population. Oncotarget, 8, 107149-107156. https://doi.org/10.18632/oncotarget.22361
|
[12]
|
季红兵, 居会祥, 孙明忠, 等. 血清胎球蛋白A水平变化与代谢综合征的相关性[J]. 检验医学, 2017, 32(8): 677-681.
|
[13]
|
许方圆, 潘雨亭, 尚文斌. 胎球蛋白B在机体病理生理过程中的作用[J]. 生理科学进展, 2017, 48(4): 274-278.
|
[14]
|
Dahlman, I., Eriksson, P., Kaaman, M., et al. (2004) 2-Heremans Schmid Glycoprotein Gene Polymorphisms Are Associated with Adipocyte Insulin Action. Diabetologia, 47, 1974-1979. https://doi.org/10.1007/s00125-004-1556-7
|
[15]
|
Haukeland, J.W., Dahl, T.B., Yndestad, A., et al. (2012) Fetuin A in Nonalcoholic Fatty Liver Disease: In Vivo and in Vitro Studies. European Journal of Endocrinology, 166, 503-510. https://doi.org/10.1530/EJE-11-0864
|
[16]
|
Mukhopadhyay, S. and Bhattacharya, S. (2016) Plasma Fetuin-A Triggers Inflammatory Changes in Macrophages and Adipocytes by Acting as an Adaptor Protein between NEFA and TLR-4. Diabetologia, 59, 859-860.
https://doi.org/10.1007/s00125-016-3866-y
|
[17]
|
Pal, D., Dasgupta, S., Kundu, R., et al. (2012) Fetuin-A Acts as an Endogenous Ligand of TLR4 to Promote Lipid-Induced Insulin Resistance. Nature Medicine, 18, 1279-1285. https://doi.org/10.1038/nm.2851
|
[18]
|
Pan, X., Kaminga, A.C., Chen, J., et al. (2020) Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression. International Journal of Environmental Re-search and Public Health, 17, 2735.
https://doi.org/10.3390/ijerph17082735
|
[19]
|
汪玉倩, 徐可, 詹月萍, 等. 华蟾素对转化生长因子-β1诱导肝星状细胞激活的作用及机制研究[J/OL]. 中国临床药理学杂志, 2022, 38(13): 1452-1456. https://doi.org/10.13699/j.cnki.1001-6821.2022.13.005
|
[20]
|
Sato, M., Kamada, Y., Takeda, Y., et al. (2015) Fetu-in-A Negatively Correlates with Liver and Vascular Fibrosis in Nonalcoholic Fatty Liver Disease Subjects. Liver Inter-national, 35, 925-935. https://doi.org/10.1111/liv.12478
|
[21]
|
Meex, R.C., Hoy, A.J., Morris, A., et al. (2015) Fe-tuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism. Cell Metabolism, 22, 1078-1089. https://doi.org/10.1016/j.cmet.2015.09.023
|
[22]
|
Momin, A.A., Bankar, M.P. and Bhoite, G.M. (2017) Association of Single Nucleotide Polymorphisms of Adiponectin Gene with Type 2 Diabetes Mellitus, and Their Influ-ence on Cardiovascular Risk Markers. Indian Journal of Clinical Biochemistry, 32, 53-60. https://doi.org/10.1007/s12291-016-0573-x
|
[23]
|
Pan, X., Wen, S.W., Bestman, P.L., et al. (2020) Fetuin-A in Metabolic Syndrome: A Systematic Review and Meta-Analysis. PLOS ONE, 15, e0229776. https://doi.org/10.1371/journal.pone.0229776
|
[24]
|
Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease.
https://www.corepubmed.com/Archive/Detail/30642126
|
[25]
|
Han, H.S., Kang, G., Kim, J.S., et al. (2016) Regula-tion of Glucose Metabolism from a Liver-Centric Perspective. Experimental & Molecular Medicine, 48, e218. https://doi.org/10.1038/emm.2015.122
|
[26]
|
Ding, H.R., Wang, J.L., Ren, H.Z., et al. (2018) Lipometabolism and Glycometabolism in Liver Diseases. BioMed Research International, 2018, Article ID: 1287127. https://doi.org/10.1155/2018/1287127
|
[27]
|
Chen, M., Liu, J., Yang, W., et al. (2017) Lipopolysaccharide Mediates Hepatic Stellate Cell Activation by Regulating Autophagy and Retinoic Acid Signaling. Autophagy, 13, 1813-1827. https://doi.org/10.1080/15548627.2017.1356550
|
[28]
|
Samuel, V.T., Liu, Z.X., Qu, X., et al. (2004) Mechanism of Hepatic Insulin Resistance in Non-Alcoholic Fatty Liver Disease. Journal of Biological Chemistry, 279, 32345-32353. https://doi.org/10.1074/jbc.M313478200
|
[29]
|
Raddatz, K., Turner, N., Frangioudakis, G., et al. (2011) Time-Dependent Effects of Prkce Deletion on Glucose Homeostasis and Hepatic Lipid Metabolism on Dietary Lipid Oversupply in Mice. Diabetologia, 54, 1447-1456.
https://doi.org/10.1007/s00125-011-2073-0
|
[30]
|
Samuel, V.T. and Shulman, G.I. (2016) The Pathogenesis of In-sulin Resistance: Integrating Signaling Pathways and Substrate Flux. Journal of Clinical Investigation, 126, 12-22. https://doi.org/10.1172/JCI77812
|
[31]
|
Satapathy, S. and Sanyal, A. (2015) Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 35, 221-235. https://doi.org/10.1055/s-0035-1562943
|
[32]
|
Nonalcoholic Fatty Liver Disease: A Systematic Review. https://www.corepubmed.com/Archive/Detail/26057287
|
[33]
|
Leptin Reverses Diabetes by Suppression of the Hypothalamic-Pituitary-Adrenal Axis.
https://www.corepubmed.com/Archive/Detail/24929951
|
[34]
|
Lebensztejn, D.M., Flisiak-Jackiewicz, M., Białok-oz-Kalinowska, I., et al. (2016) Hepatokines and Non-Alcoholic Fatty Liver Disease. Acta Biochimica Polonica, 63, 459-467. https://doi.org/10.18388/abp.2016_1252
|
[35]
|
Li, Z., Lin, M., Liu, C., et al. (2018) Fetuin-B Links Non-alcoholic Fatty Liver Disease to Type 2 Diabetes via Inducing Insulin Resistance: Association and Path Analyses. Cyto-kine, 108, 145-150. https://doi.org/10.1016/j.cyto.2018.03.023
|
[36]
|
Shim, Y.S., Kang, M.J., Oh, Y.J., et al. (2017) Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children. Journal of Atherosclerosis and Thrombosis, 24, 1031-1038.
https://doi.org/10.5551/jat.38323
|